These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38841730)

  • 1. Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up.
    Granvik C; Andersson S; Andersson L; Brorsson C; Forsell M; Ahlm C; Normark J; Edin A
    Brain Behav; 2024 Jun; 14(6):e3574. PubMed ID: 38841730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional Sleep Health Prior to SARS-CoV-2 Infection and Risk of Post-COVID-19 Condition.
    Wang S; Huang T; Weisskopf MG; Kang JH; Chavarro JE; Roberts AL
    JAMA Netw Open; 2023 May; 6(5):e2315885. PubMed ID: 37252741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection.
    Petersen M; Becker B; Schell M; Mayer C; Naegele FL; Petersen E; Twerenbold R; Thomalla G; Cheng B; Betz C; Hoffmann AS
    Sci Rep; 2024 Jun; 14(1):13396. PubMed ID: 38862636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection.
    Cristillo V; Pilotto A; Cotti Piccinelli S; Zoppi N; Bonzi G; Gipponi S; Sattin D; Schiavolin S; Raggi A; Bezzi M; Leonardi M; Padovani A;
    J Am Geriatr Soc; 2021 Oct; 69(10):2778-2780. PubMed ID: 34019707
    [No Abstract]   [Full Text] [Related]  

  • 5. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Patient-Reported and Clinically Tested Olfactory Dysfunction in a Population Screened for COVID-19.
    Villerabel C; Makinson A; Jaussent A; Picot MC; Nègre-Pagès L; Rouvière JA; Favier V; Crampette L; Morquin D; Reynes J; Le Moing V; Tuaillon E; Venail F
    JAMA Otolaryngol Head Neck Surg; 2021 Mar; 147(3):271-279. PubMed ID: 33410887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
    Schild AK; Goereci Y; Scharfenberg D; Klein K; Lülling J; Meiberth D; Schweitzer F; Stürmer S; Zeyen P; Sahin D; Fink GR; Jessen F; Franke C; Onur OA; Kessler J; Warnke C; Maier F
    J Neurol; 2023 Mar; 270(3):1215-1223. PubMed ID: 36422669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral microstructural alterations in Post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigue.
    Hosp JA; Reisert M; Dressing A; Götz V; Kellner E; Mast H; Arndt S; Waller CF; Wagner D; Rieg S; Urbach H; Weiller C; Schröter N; Rau A
    Nat Commun; 2024 May; 15(1):4256. PubMed ID: 38762609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 naïve individuals.
    Bland AR; Barraclough M; Trender WR; Mehta MA; Hellyer PJ; Hampshire A; Penner IK; Elliott R; Harenwall S
    Sci Rep; 2024 Jun; 14(1):13368. PubMed ID: 38862569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive Intake of a Multiple Micronutrient Supplement during Mild, Acute SARS-CoV-2 Infection to Reduce the Post-Acute COVID-19 Condition: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Tomasa-Irriguible TM; Monfà R; Miranda-Jiménez C; Morros R; Robert N; Bordejé-Laguna L; Vidal S; Torán-Monserrat P; Barriocanal AM
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints.
    Grunden N; Calabria M; García-Sánchez C; Pons C; Arroyo JA; Gómez-Ansón B; Estévez-García MDC; Belvís R; Morollón N; Cordero-Carcedo M; Mur I; Pomar V; Domingo P
    PLoS One; 2024; 19(8):e0302415. PubMed ID: 39116061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: Results from chemosensitive testing eight months after the acute infection.
    Hintschich CA; Fischer R; Hummel T; Wenzel JJ; Bohr C; Vielsmeier V
    PLoS One; 2022; 17(3):e0265686. PubMed ID: 35320821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive profile in multiple sclerosis and post-COVID condition: a comparative study using a unified taxonomy.
    Delgado-Alonso C; Delgado-Alvarez A; Díez-Cirarda M; Oliver-Mas S; Cuevas C; Montero-Escribano P; Ramos-Leví AM; Gil-Moreno MJ; López-Carbonero JI; Hermann BP; Matias-Guiu J; Matias-Guiu JA
    Sci Rep; 2024 Apr; 14(1):9806. PubMed ID: 38684843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.
    Collins E; Galipeau Y; Arnold C; Bhéreur A; Booth R; Buchan AC; Cooper C; Crawley AM; McCluskie PS; McGuinty M; Pelchat M; Rocheleau L; Saginur R; Gravel C; Hawken S; Langlois MA; Little J
    Front Public Health; 2024; 12():1276391. PubMed ID: 38784593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.
    Boscolo-Rizzo P; Menegaldo A; Fabbris C; Spinato G; Borsetto D; Vaira LA; Calvanese L; Pettorelli A; Sonego M; Frezza D; Bertolin A; Cestaro W; Rigoli R; D'Alessandro A; Tirelli G; Da Mosto MC; Menini A; Polesel J; Hopkins C
    Chem Senses; 2021 Jan; 46():. PubMed ID: 33575808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
    Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy.
    Pasquini J; Maremmani C; Salvadori S; Silani V; Ticozzi N
    Neurol Sci; 2021 Jun; 42(6):2183-2189. PubMed ID: 33768438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results.
    Jensen MM; Larsen KD; Homøe AS; Simonsen AL; Arndal E; Koch A; Samuelsen GB; Nielsen XC; Todsen T; Homøe P
    PLoS One; 2022; 17(10):e0275518. PubMed ID: 36191024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.